Australian Clinical Labs (ASX:ACL) — Material Events
ASX:ACL · 6 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
ACL Delivers Earnings Growth Amid Market Challenges and Wage PressuresMedium
ACL reports 1H26 earnings growth despite revenue dip; updates FY26 guidance and addresses wage impacts
16 Feb 2026
·Financial Results
·85
Australian Clinical Labs Reports FY26 EBIT Growth Amid Market PressuresMedium
Australian Clinical Labs reports FY26 EBIT growth and margin expansion; FY27 guidance reflects stable margins amid market challenges
17 Aug 2026
·Financial Results
·85
Australian Clinical Labs Names Greg Horan as New CEO to Succeed Melinda McGrathMedium
Australian Clinical Labs appoints Greg Horan as new Group CEO effective August 2026
28 May 2026
·Executive Appointment
·75
Australian Clinical Labs Faces New Class Action Over 2022 Medlab CyberattackMedium
Australian Clinical Labs faces class action over 2022 Medlab Pathology cyberattack
21 Apr 2026
·Legal Proceedings Announcement
·Unexpected
·70
ACL Agrees to $6.2M Settlement Over Medlab Cyberattack Privacy BreachMedium
ACL settles Privacy Act proceeding over Medlab cyberattack with $6.2 million penalty agreement
29 Sept 2025
·Regulatory Update
·65
No articles in this tier for the last 12 months.
Market Mentions
4
- appeared in market wrap coverage
These are market wrap articles where Australian Clinical Labs (ASX:ACL) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Healthcare Wrap - Week 22 (25 May -> 29 May) 2026
30 May 2026
Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026
25 Apr 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026